Command Palette

Search for a command to run...

SYNGENE

633.75-2.69%
Market Cap
₹26,251.50 Cr
Stock P/E
51.76
ROCE
15.55%
ROE
13.18%
Book Value
₹117.50

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Institution
Public
Others

From Last Concall

POSITIVES
  • Revenue growth supported by Research Services and margin expansion.
  • EBITDA margin expansion despite revenue growth.
NEGATIVES
  • Biotech funding headwinds and macro uncertainty could impact long-term growth.
  • Inventory rebalancing in Biologics may weigh on near-term performance.

Peers Summary

Growth Outperformer

Syngene International Ltd. stands out in the business support sector with robust profitability and growth metrics, despite a relatively high valuation. It shows solid revenue growth and efficient capital utilization compared to its peers, making it an attractive investment prospect. However, some peers are significantly overvalued or financially distressed, highlighting Syngene as a balanced choice for growth-focused investors.

Key Points
  • Syngene has the highest revenue growth over 3 years and impressive EPS growth.
  • International Gemmological Institute boasts the highest ROE and ROA, while Smartworks shows concerning financial metrics with high debt and negative profitability.
  • Just Dial is the best value pick, providing a low PE ratio with decent profitability.
Top Performers
International Gemmological Institute (India) Ltd.

Highest ROE (76.58%) and ROA (64.16%), indicating exceptional profitability and efficiency.

CMS Info Systems Ltd.

Strong profitability metrics with a ROE of 20.30% and a low PE ratio of 20.70, suggesting value.

Syngene International Ltd.

Consistent growth with a 4.41% YoY revenue increase and solid EPS growth, despite a higher PE ratio.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.